Delivery Order N6264523D5005-N0018924FZ278
Award Date
2/28/24
Potential Completion Date
3/4/24
Potential Value
$67K
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This is a firm fixed price delivery order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $110,534.40 contract is for the provision of various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This delivery order is issued under...
This firm fixed-price delivery order was awarded by the Southeast Area of the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $95,931 award is for the provision of an Illumina MiSeq System, a high-throughput DNA sequencing platform, to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This delivery order is part of a...
This federal contract award, valued at $89,232.71, was issued by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc. Illumina, a manufacturer of genomic sequencing instruments and reagents, is providing health check services for BUMED's MiSeq and NextSeq 500 sequencing systems under this firm fixed price purchase order. The award is not associated with a larger contract vehicle and does not have a set-aside designation. Illumina has previously supported genomic research and...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract, valued at $80,858.46, is for the delivery of various Illumina sequencing systems, reagents, and consumables to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This award is made under an...
This is a firm fixed-price Delivery Order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $38,027.60 award is for the provision of lab supplies, specifically Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and consumables. This Delivery Order is likely part of a larger Indefinite...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $68,512.50, is for the delivery of various Illumina sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models, along with accompanying reagents, consumables, and support services. The contract is not designated as a set-aside. Illumina has...
This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
This is a sole-source federal contract award from the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $76,243.05 firm fixed-price purchase order is for Illumina's RNA Prep with Enrichment kits, IDT for Illumina DNA/RNA UD Indexes, Respiratory Virus Oligo Panel v2, and MiSeq Reagent Kits to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research...